{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:50:16Z","timestamp":1791287416358,"version":"4.1.0"},"reference-count":144,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02066","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T08:08:31Z","timestamp":1568102911000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":77,"title":["Innate Immunity in the Central Nervous System: A Missing Piece of the Autoimmune Encephalitis Puzzle?"],"prefix":"10.3389","volume":"10","author":[{"given":"Robb","family":"Wesselingh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Butzkueven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Buzzard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Tarlinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence J.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mastura","family":"Monif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/JLB.1RU1117-428R","article-title":"Blood-brain barrier and its function during inflammation and autoimmunity","volume":"103","author":"Sonar","year":"2018","journal-title":"J Leukoc Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.2337\/db09-1606","article-title":"TNF-alpha signals through PKCzeta\/NF-kappaB to alter the tight junction complex and increase retinal endothelial cell permeability","volume":"59","author":"Aveleira","year":"2010","journal-title":"Diabetes."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.0808698106","article-title":"VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown","volume":"106","author":"Argaw","year":"2009","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B4","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.4049\/jimmunol.177.8.5574","article-title":"IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program","volume":"177","author":"Argaw","year":"2006","journal-title":"J Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/brain\/123.4.698","article-title":"Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium","volume":"123","author":"Harkness","year":"2000","journal-title":"Brain."},{"key":"B6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.4049\/jimmunol.0802258","article-title":"IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis","volume":"183","author":"McCandless","year":"2009","journal-title":"J Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1084\/jem.20151437","article-title":"Myeloid cell transmigration across the CNS vasculature triggers IL-1beta-driven neuroinflammation during autoimmune encephalomyelitis in mice","volume":"213","author":"Levesque","year":"2016","journal-title":"J Exp Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"E1194","DOI":"10.1073\/pnas.1714948115","article-title":"IL-1beta enables CNS access to CCR2(hi) monocytes and the generation of pathogenic cells through GM-CSF released by CNS endothelial cells","volume":"115","author":"Pare","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/brain\/awm295","article-title":"The blood-brain barrier induces differentiation of migrating monocytes into Th17\u2013polarizing dendritic cells","volume":"131","author":"Ifergan","year":"2008","journal-title":"Brain."},{"key":"B10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.immuni.2017.01.007","article-title":"Dysregulation of the Cytokine GM-CSF Induces Spontaneous Phagocyte Invasion and Immunopathology in the Central Nervous System","volume":"46","author":"Spath","year":"2017","journal-title":"Immunity."},{"key":"B11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/cne.1187","article-title":"Regulation of the gene encoding the monocyte chemoattractant protein 1 (MCP-1) in the mouse and rat brain in response to circulating LPS and proinflammatory cytokines","volume":"434","author":"Thibeault","year":"2001","journal-title":"J Comp Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1046\/j.1471-4159.2001.00603.x","article-title":"Circulating cell wall components derived from gram-negative, not gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS","volume":"79","author":"Laflamme","year":"2001","journal-title":"J Neurochem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1161\/01.STR.0000259709.16654.8f","article-title":"Absence of the chemokine receptor CCR2 protects against cerebral ischemia\/reperfusion injury in mice","volume":"38","author":"Dimitrijevic","year":"2007","journal-title":"Stroke."},{"key":"B14","doi-asserted-by":"publisher","first-page":"19053","DOI":"10.1074\/jbc.M109.000521","article-title":"Caveolae-mediated internalization of occludin and claudin-5 during CCL2\u2013induced tight junction remodeling in brain endothelial cells","volume":"284","author":"Stamatovic","year":"2009","journal-title":"J Biol Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science."},{"key":"B16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1742-2094-11-98","article-title":"Neuroinflammation and M2 microglia: the good, the bad, and the inflamed","volume":"11","author":"Cherry","year":"2014","journal-title":"J Neuroinflammation."},{"key":"B17","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/nn1472","article-title":"ATP mediates rapid microglial response to local brain injury in vivo","volume":"8","author":"Davalos","year":"2005","journal-title":"Nat Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/jnen\/61.11.1013","article-title":"Broad expression of Toll-like receptors in the human central nervous system","volume":"61","author":"Bsibsi","year":"2002","journal-title":"J Neuropathol Exp Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.4049\/jimmunol.173.6.3916","article-title":"Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs","volume":"173","author":"Olson","year":"2004","journal-title":"J Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1742-2094-10-86","article-title":"Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain","volume":"10","author":"Selenica","year":"2013","journal-title":"J Neuroinflammation."},{"key":"B21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1742-2094-9-156","article-title":"Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation","volume":"9","author":"van Horssen","year":"2012","journal-title":"J Neuroinflammation."},{"key":"B22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/jnr.20488","article-title":"Microglial cell activation and proliferation precedes the onset of CNS autoimmunity","volume":"81","author":"Ponomarev","year":"2005","journal-title":"J Neurosci Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms18030504","article-title":"The diverse roles of microglia in the neurodegenerative aspects of Central Nervous System (CNS) autoimmunity","volume":"18","author":"Thompson","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1191\/1352458505ms1140oa","article-title":"Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study","volume":"11","author":"Versijpt","year":"2005","journal-title":"Mult Scler."},{"key":"B25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S1359-6101(97)00018-X","article-title":"TGF-beta in the central nervous system: potential roles in ischemic injury and neurodegenerative diseases","volume":"8","author":"Pratt","year":"1997","journal-title":"Cytokine Growth Factor Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/glia.22904","article-title":"Mechanism of microglia neuroprotection: involvement of P2X7, TNFalpha, and valproic acid","volume":"64","author":"Masuch","year":"2016","journal-title":"Glia."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1523\/JNEUROSCI.0514-05.2005","article-title":"Microglia overexpressing the macrophage colony-stimulating factor receptor are neuroprotective in a microglial-hippocampal organotypic coculture system","volume":"25","author":"Mitrasinovic","year":"2005","journal-title":"J Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1177\/0271678X17694185","article-title":"Depletion of microglia exacerbates postischemic inflammation and brain injury","volume":"37","author":"Jin","year":"2017","journal-title":"J Cereb Blood Flow Metab."},{"key":"B29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/ana.10092","article-title":"Inhibition of autoimmune encephalomyelitis by a tetracycline","volume":"51","author":"Popovic","year":"2002","journal-title":"Ann Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMoa1608889","article-title":"Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis","volume":"376","author":"Metz","year":"2017","journal-title":"N Engl J Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/glia.23007","article-title":"Critical data-based re-evaluation of minocycline as a putative specific microglia inhibitor","volume":"64","author":"Moller","year":"2016","journal-title":"Glia."},{"key":"B32","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nm1177","article-title":"Experimental autoimmune encephalomyelitis repressed by microglial paralysis","volume":"11","author":"Heppner","year":"2005","journal-title":"Nat Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jneuroim.2012.12.005","article-title":"Fingolimod phosphate promotes the neuroprotective effects of microglia","volume":"256","author":"Noda","year":"2013","journal-title":"J Neuroimmunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11481-010-9248-1","article-title":"Glatiramer acetate modulates TNF-alpha and IL-10 secretion in microglia and promotes their phagocytic activity","volume":"6","author":"Pul","year":"2011","journal-title":"J Neuroimmune Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.immuni.2008.03.011","article-title":"Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system","volume":"28","author":"Prinz","year":"2008","journal-title":"Immunity."},{"key":"B36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1074-7613(03)00174-2","article-title":"Blood monocytes consist of two principal subsets with distinct migratory properties","volume":"19","author":"Geissmann","year":"2003","journal-title":"Immunity."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/nn2015","article-title":"Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions","volume":"10","author":"Mildner","year":"2007","journal-title":"Nat Neurosci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1002\/glia.22711","article-title":"In acute experimental autoimmune encephalomyelitis, infiltrating macrophages are immune activated, whereas microglia remain immune suppressed","volume":"62","author":"Vainchtein","year":"2014","journal-title":"Glia."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1084\/jem.20132477","article-title":"Differential roles of microglia and monocytes in the inflamed central nervous system","volume":"211","author":"Yamasaki","year":"2014","journal-title":"J Exp Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12974-015-0443-0","article-title":"Ccr2 deletion dissociates cavity size and tau pathology after mild traumatic brain injury","volume":"12","author":"Gyoneva","year":"2015","journal-title":"J Neuroinflammation."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1089\/neu.2013.3252","article-title":"CCR2 deficiency impairs macrophage infiltration and improves cognitive function after traumatic brain injury","volume":"31","author":"Hsieh","year":"2014","journal-title":"J Neurotrauma."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1002\/cne.23463","article-title":"Migration of bone marrow-derived cells into the central nervous system in models of neurodegeneration","volume":"521","author":"Lampron","year":"2013","journal-title":"J Comp Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1093\/brain\/awp144","article-title":"CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system","volume":"132","author":"Mildner","year":"2009","journal-title":"Brain."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e2005264","DOI":"10.1371\/journal.pbio.2005264","article-title":"Peripherally derived macrophages modulate microglial function to reduce inflammation after CNS injury","volume":"16","author":"Greenhalgh","year":"2018","journal-title":"PLoS Biol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clim.2016.06.017","article-title":"The contribution of neutrophils to CNS autoimmunity","volume":"189","author":"Pierson","year":"2018","journal-title":"Clin Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.4049\/jimmunol.1400401","article-title":"Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases","volume":"193","author":"Aube","year":"2014","journal-title":"J Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"14965","DOI":"10.1523\/JNEUROSCI.3794-09.2009","article-title":"Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis","volume":"29","author":"Soulika","year":"2009","journal-title":"J Neurosci."},{"key":"B48","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.4049\/jimmunol.161.11.6421","article-title":"Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis","volume":"161","author":"McColl","year":"1998","journal-title":"J Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.4049\/jimmunol.1202613","article-title":"Neutrophils amplify autoimmune central nervous system infiltrates by maturing local APCs","volume":"191","author":"Steinbach","year":"2013","journal-title":"J Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/ni1430","article-title":"CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE","volume":"8","author":"Bailey","year":"2007","journal-title":"Nat Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(14)70305-9","article-title":"Role of the innate and adaptive immune responses in the course of multiple sclerosis","volume":"14","author":"Hemmer","year":"2015","journal-title":"Lancet Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3389\/fimmu.2017.00652","article-title":"Expanding role of T cells in human autoimmune diseases of the central nervous system","volume":"8","author":"Pilli","year":"2017","journal-title":"Front Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.07.006","article-title":"Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness","volume":"180","author":"Link","year":"2006","journal-title":"J Neuroimmunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/5532","article-title":"Identification of autoantibodies associated with myelin damage in multiple sclerosis","volume":"5","author":"Genain","year":"1999","journal-title":"Nat Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N Engl J Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S1474-4422(14)70028-6","article-title":"Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial","volume":"13","author":"Kappos","year":"2014","journal-title":"Lancet Neurol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1177\/1352458516664210","article-title":"Increased ex vivo antigen presentation profile of B cells in multiple sclerosis","volume":"23","author":"Mathias","year":"2017","journal-title":"Mult Scler."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1177\/1352458514560923","article-title":"Decreased Dicer expression is linked to increased expression of co-stimulatory molecule CD80 on B cells in multiple sclerosis","volume":"21","author":"Aung","year":"2015","journal-title":"Mult Scler."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1172\/JCI119455","article-title":"Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy","volume":"99","author":"Genc","year":"1997","journal-title":"J Clin Invest."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1084\/jem.20130699","article-title":"MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies","volume":"210","author":"Molnarfi","year":"2013","journal-title":"J Exp Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature."},{"key":"B63","doi-asserted-by":"publisher","first-page":"18460","DOI":"10.1073\/pnas.0809850105","article-title":"IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells","volume":"105","author":"Korn","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1084\/jem.20111675","article-title":"B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6\u2013producing B cells","volume":"209","author":"Barr","year":"2012","journal-title":"J Exp Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cell.2018.08.011","article-title":"Memory B Cells Activate Brain-Homing, Autoreactive CD4(+) T Cells in Multiple Sclerosis","volume":"175","author":"Jelcic","year":"2018","journal-title":"Cell."},{"key":"B66","doi-asserted-by":"publisher","first-page":"310ra166","DOI":"10.1126\/scitranslmed.aab4176","article-title":"Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy","volume":"7","author":"Li","year":"2015","journal-title":"Sci Transl Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-Mediated Encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N Engl J Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune Encephalitis Epidemiology and a comparison to Infectious Encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann Neurol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","article-title":"Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients","volume":"124","author":"Graus","year":"2001","journal-title":"Brain."},{"key":"B70","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ncl.2018.04.015","article-title":"Paraneoplastic Neurologic Syndromes","volume":"36","author":"Rosenfeld","year":"2018","journal-title":"Neurol Clin."},{"key":"B71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-8970-0","article-title":"Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies","author":"Bost","year":"2018","journal-title":"J Neurol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/ane.12556","article-title":"Initial serum thyroid peroxidase antibodies and long-term outcomes in SREAT","volume":"134","author":"Litmeier","year":"2016","journal-title":"Acta Neurol Scand."},{"key":"B76","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/ane.12575","article-title":"Suspected antibody negative autoimmune limbic encephalitis: outcome of immunotherapy","volume":"135","author":"von Rhein","year":"2017","journal-title":"Acta Neurol Scand."},{"key":"B78","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1468-1331.2010.03220.x","article-title":"Screening for tumours in paraneoplastic syndromes: report of an EFNS task force","volume":"18","author":"Titulaer","year":"2011","journal-title":"Eur J Neurol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.autrev.2011.03.001","article-title":"Autoantibodies to intracellular antigens: generation and pathogenetic role","volume":"10","author":"Racanelli","year":"2011","journal-title":"Autoimmun Rev."},{"key":"B80","doi-asserted-by":"publisher","first-page":"630602","DOI":"10.1155\/2013\/630602","article-title":"Cell-mediated immune responses in paraneoplastic neurological syndromes","volume":"2013","author":"Zaborowski","year":"2013","journal-title":"Clin Dev Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1007\/s00415-016-8277-y","article-title":"Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study","volume":"263","author":"Heine","year":"2016","journal-title":"J Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1212\/WNL.0000000000002635","article-title":"Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort","volume":"86","author":"Lee","year":"2016","journal-title":"Neurology."},{"key":"B83","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s13311-016-0442-6","article-title":"Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study","volume":"13","author":"Lee","year":"2016","journal-title":"Neurotherapeutics."},{"key":"B84","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1212\/WNL.0000000000003536","article-title":"Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis","volume":"88","author":"Scheibe","year":"2017","journal-title":"Neurology."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1756285617722347","DOI":"10.1177\/1756285617722347","article-title":"Treatment strategies for autoimmune encephalitis","volume":"11","author":"Shin","year":"2018","journal-title":"Ther Adv Neurol Disord."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain."},{"key":"B87","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00401-009-0582-4","article-title":"Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma","volume":"118","author":"Tuzun","year":"2009","journal-title":"Acta Neuropathol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1212\/WNL.0b013e318228c136","article-title":"Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis","volume":"77","author":"Martinez-Hernandez","year":"2011","journal-title":"Neurology."},{"key":"B89","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2169\/internalmedicine.47.0547","article-title":"Neuropathological studies of patients with possible non-herpetic acute limbic encephalitis and so-called acute juvenile female non-herpetic encephalitis","volume":"47","author":"Okamoto","year":"2008","journal-title":"Intern Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/RLU.0000000000000546","article-title":"18F-FDG PET\/CT in anti-LGI1 encephalitis: initial and follow-up findings","volume":"40","author":"Park","year":"2015","journal-title":"Clin Nucl Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1097\/WNR.0000000000000851","article-title":"Persistence of parenchymal and perivascular T-cells in treatment-refractory anti-N-methyl-D-aspartate receptor encephalitis","volume":"28","author":"Filatenkov","year":"2017","journal-title":"Neuroreport."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1212\/WNL.0b013e3181a55eb3","article-title":"Histopathology of VGKC antibody-associated limbic encephalitis","volume":"72","author":"Khan","year":"2009","journal-title":"Neurology."},{"key":"B93","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/j.1468-1331.2010.03180.x","article-title":"Brain immunohistopathological study in a patient with anti-NMDAR encephalitis","volume":"18","author":"Camdessanche","year":"2011","journal-title":"Eur J Neurol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/dmcn.12036","article-title":"Cerebrospinal fluid CD19(+) B-cell expansion in N-methyl-D-aspartate receptor encephalitis","volume":"55","author":"Dale","year":"2013","journal-title":"Dev Med Child Neurol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1093\/abbs\/gmy137","article-title":"Th17 cells were recruited and accumulated in the cerebrospinal fluid and correlated with the poor prognosis of anti-NMDAR encephalitis","volume":"50","author":"Zeng","year":"2018","journal-title":"Acta Biochim Biophys Sin."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1212\/NXI.0000000000000232","article-title":"Evidence of a pathogenic role for CD8(+) T cells in anti-GABAB receptor limbic encephalitis","volume":"3","author":"Golombeck","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B97","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neulet.2018.12.003","article-title":"Prediction of neutrophil-to-lymphocyte ratio in the diagnosis and progression of autoimmune encephalitis","volume":"694","author":"Zeng","year":"2019","journal-title":"Neurosci Lett."},{"key":"B98","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12974-016-0507-9","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid","volume":"13","author":"Liba","year":"2016","journal-title":"J Neuroinflammation."},{"key":"B99","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/dmcn.13431","article-title":"Cerebrospinal fluid cyto-\/chemokine profile during acute herpes simplex virus induced anti-N-Methyl-d-aspartate receptor encephalitis and in chronic neurological sequelae","volume":"59","author":"Kothur","year":"2017","journal-title":"Dev Med Child Neurol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"e0161656","DOI":"10.1371\/journal.pone.0161656","article-title":"Utility of CSF Cytokine\/chemokines as markers of active intrathecal inflammation: comparison of demyelinating, anti-NMDAR and enteroviral encephalitis","volume":"11","author":"Kothur","year":"2016","journal-title":"PLoS ONE."},{"key":"B101","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cyto.2015.10.001","article-title":"CSF cytokines\/chemokines as biomarkers in neuroinflammatory CNS disorders: a systematic review","volume":"77","author":"Kothur","year":"2016","journal-title":"Cytokine."},{"key":"B102","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jneuroim.2016.05.023","article-title":"Distinct intrathecal interleukin-17\/interleukin-6 activation in anti-N-methyl-d-aspartate receptor encephalitis","volume":"297","author":"Byun","year":"2016","journal-title":"J Neuroimmunol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jneuroim.2017.01.012","article-title":"Raised cerebrospinal fluid BAFF and APRIL levels in anti-N-methyl-d-aspartate receptor encephalitis: correlation with clinical outcome","volume":"305","author":"Deng","year":"2017","journal-title":"J Neuroimmunol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jns.2015.03.036","article-title":"B-cell-activating factor belonging to the tumor necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) levels in cerebrospinal fluid of patients with meningoencephalitis","volume":"352","author":"Kimura","year":"2015","journal-title":"J Neurol Sci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/jamaneurol.2014.2956","article-title":"Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response","volume":"72","author":"Leypoldt","year":"2015","journal-title":"JAMA Neurol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3109\/00207454.2011.648762","article-title":"Comparison of the cytokine profiles of patients with neuronal-antibody-associated central nervous system disorders","volume":"122","author":"Ulusoy","year":"2012","journal-title":"Int J Neurosci."},{"key":"B107","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jneuroim.2017.11.016","article-title":"Cerebrospinal fluid pentraxin 3 and CD40 ligand in anti-N-menthyl-d-aspartate receptor encephalitis","volume":"315","author":"Liu","year":"2018","journal-title":"J Neuroimmunol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/ana.25374","article-title":"Tocilizumab treatment for new onset refractory status epilepticus","volume":"84","author":"Jun","year":"2018","journal-title":"Ann Neurol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/ane.12894","article-title":"Serum cystatin C and anti-N-methyl-D-aspartate receptor encephalitis","volume":"137","author":"Shu","year":"2018","journal-title":"Acta Neurol Scand."},{"key":"B110","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuint.2017.02.005","article-title":"Serum uric acid and anti-N-methyl-d-aspartate receptor encephalitis","volume":"108","author":"Shu","year":"2017","journal-title":"Neurochem Int."},{"key":"B111","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci."},{"key":"B112","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/brain\/awu310","article-title":"Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice","volume":"138","author":"Planaguma","year":"2015","journal-title":"Brain."},{"key":"B113","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1093\/brain\/aww208","article-title":"Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis","volume":"139","author":"Kreye","year":"2016","journal-title":"Brain."},{"key":"B114","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000002125","article-title":"Autoimmune post-herpes simplex encephalitis of adults and teenagers","volume":"85","author":"Armangue","year":"2015","journal-title":"Neurology."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1756286418768778","DOI":"10.1177\/1756286418768778","article-title":"Postherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy","volume":"11","author":"Alexopoulos","year":"2018","journal-title":"Ther Adv Neurol Disord."},{"key":"B117","doi-asserted-by":"publisher","first-page":"e458","DOI":"10.1212\/NXI.0000000000000458","article-title":"Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection","volume":"5","author":"Salovin","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B118","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.4049\/jimmunol.175.7.4189","article-title":"Cutting edge: TLR2\u2013mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus","volume":"175","author":"Aravalli","year":"2005","journal-title":"J Immunol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.braindev.2017.12.007","article-title":"Cytokine\/chemokine elevation during the transition phase from HSV encephalitis to autoimmune anti-NMDA receptor encephalitis","volume":"40","author":"Omae","year":"2018","journal-title":"Brain Dev."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bcr-2016-218893","article-title":"Delayed LGI1 seropositivity in voltage-gated potassium channel (VGKC)-complex antibody limbic encephalitis","volume":"2017","author":"Sweeney","year":"2017","journal-title":"BMJ Case Rep."},{"key":"B121","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/BF03401973","article-title":"ApoE deficiency compromises the blood brain barrier especially after injury","volume":"7","author":"Methia","year":"2001","journal-title":"Mol Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/mp.2013.110","article-title":"Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity","volume":"19","author":"Hammer","year":"2014","journal-title":"Mol Psychiatry."},{"key":"B123","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.radcr.2017.06.004","article-title":"Arterial spin labeling perfusion imaging demonstrates cerebral hyperperfusion in anti-NMDAR encephalitis","volume":"12","author":"Sachs","year":"2017","journal-title":"Radiol Case Rep."},{"key":"B124","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1212\/NXI.0000000000000352","article-title":"Abnormal brain metabolism on FDG-PET\/CT is a common early finding in autoimmune encephalitis","volume":"4","author":"Probasco","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.2967\/jnumed.116.184333","article-title":"Diagnostic Value of (18)F-FDG PET\/CT Versus MRI in the setting of antibody-specific autoimmune encephalitis","volume":"58","author":"Solnes","year":"2017","journal-title":"J Nucl Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.1212\/NXI.0000000000000413","article-title":"Decreased occipital lobe metabolism by FDG-PET\/CT: an anti-NMDA receptor encephalitis biomarker","volume":"5","author":"Probasco","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B127","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ebcr.2014.09.005","article-title":"Electroencephalographic and fluorodeoxyglucose-positron emission tomography correlates in anti-N-methyl-d-aspartate receptor autoimmune encephalitis","volume":"2","author":"Probasco","year":"2014","journal-title":"Epilepsy Behav Case Rep."},{"key":"B128","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1471-2377-14-136","article-title":"Anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis show distinct patterns of brain glucose metabolism in 18F-fluoro-2\u2013deoxy-d-glucose positron emission tomography","volume":"14","author":"Wegner","year":"2014","journal-title":"BMC Neurol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/ana.25216","article-title":"Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis","volume":"83","author":"Mueller","year":"2018","journal-title":"Ann Neurol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ana.24860","article-title":"Anti-LGI1 encephalitis is associated with unique HLA subtypes","volume":"81","author":"Kim","year":"2017","journal-title":"Ann Neurol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1093\/brain\/awy109","article-title":"Distinct HLA associations of LGI1 and CASPR2\u2013antibody diseases","volume":"141","author":"Binks","year":"2018","journal-title":"Brain."},{"key":"B132","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/jnnp-2018-319714","article-title":"HLA class II allele DRB1*16:02 is associated with anti-NMDAR encephalitis","volume":"90","author":"Shu","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.08.001","article-title":"Immunological perspectives of temporal lobe seizures","volume":"263","author":"Liimatainen","year":"2013","journal-title":"J Neuroimmunol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.bbi.2015.11.016","article-title":"Peripheral leukocyte profile in people with temporal lobe epilepsy reflects the associated proinflammatory state","volume":"53","author":"Vieira","year":"2016","journal-title":"Brain Behav Immun."},{"key":"B135","doi-asserted-by":"publisher","first-page":"E5665","DOI":"10.1073\/pnas.1604263113","article-title":"Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus","volume":"113","author":"Varvel","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B136","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1093\/brain\/awv257","article-title":"Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model","volume":"138","author":"Wright","year":"2015","journal-title":"Brain."},{"key":"B137","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/epi.14662","article-title":"A mouse model of seizures in anti-N-methyl-d-aspartate receptor encephalitis","volume":"60","author":"Taraschenko","year":"2019","journal-title":"Epilepsia."},{"key":"B138","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/13803395.2017.1329408","article-title":"Cognitive outcomes following anti-N-methyl-D-aspartate receptor encephalitis: a systematic review","volume":"40","author":"McKeon","year":"2018","journal-title":"J Clin Exp Neuropsychol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.ebiom.2015.05.027","article-title":"Selective impairment of spatial cognition caused by autoantibodies to the N-Methyl-D-aspartate receptor","volume":"2","author":"Chang","year":"2015","journal-title":"EBioMedicine."},{"key":"B140","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jns.2017.03.020","article-title":"Global brain atrophy and metabolic dysfunction in LGI1 encephalitis: a prospective multimodal MRI study","volume":"376","author":"Szots","year":"2017","journal-title":"J Neurol Sci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/acn3.656","article-title":"Cerebral autoinflammatory disease treated with anakinra","volume":"5","author":"Jang","year":"2018","journal-title":"Ann Clin Transl Neurol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1158\/1535-7163.MCT-16-0124","article-title":"Blocking the CCL2\u2013CCR2 axis using CCL2\u2013neutralizing antibody is an effective therapy for hepatocellular cancer in a mouse model","volume":"16","author":"Teng","year":"2017","journal-title":"Mol Cancer Ther."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/med.21553","article-title":"Recent clinical trends in Toll-like receptor targeting therapeutics","volume":"39","author":"Anwar","year":"2019","journal-title":"Med Res Rev."},{"key":"B144","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3389\/fphys.2017.00508","article-title":"Inhibition of toll-like receptor signaling as a promising therapy for inflammatory diseases: a journey from molecular to nano therapeutics","volume":"8","author":"Gao","year":"2017","journal-title":"Front Physiol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02066\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T02:25:29Z","timestamp":1695176729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02066\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,10]]},"references-count":144,"alternative-id":["10.3389\/fimmu.2019.02066"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02066","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,10]]},"article-number":"2066"}}